Lithuania vs Morocco: Number of clinical trials

Lithuania
5 trials
in 2024
Morocco
5 trials
in 2024
Lithuania rank
85th
Morocco rank
85th

Number of clinical trials over time

  • Lithuania
  • Morocco
05101520200620152024

How they compare

Lithuania currently reports 5 trials against 5 trials in Morocco, a difference of 0 trials.

The two have swapped places 7 times across 16 shared years of data; in 2007 it was Lithuania ahead.

Lithuania ranks 85th and Morocco ranks 85th of 153 countries.

Lithuania has averaged higher in every one of the 3 decades both report.

Head to head by decade

Decade Lithuania Morocco Difference Ahead
2000s 2.5 trials 2 trials 0.5 trials Lithuania
2010s 4.89 trials 2.22 trials 2.67 trials Lithuania
2020s 12.8 trials 4.8 trials 8 trials Lithuania

Averages of every year both report within each decade.

Frequently asked questions

Which has higher number of clinical trials, Lithuania or Morocco?
Lithuania, at 5 trials against 5 trials in Morocco as of 2024.
What is the difference in number of clinical trials between Lithuania and Morocco?
0 trials, with Lithuania ahead.
How many years of comparable data are there for Lithuania and Morocco?
16 years are reported by both, from 2007 to 2024.
How do Lithuania and Morocco rank globally for number of clinical trials?
Lithuania ranks 85th and Morocco ranks 85th of 153 countries.
Where does this data come from?
ClinicalTrials.gov (2025) – with major processing by Our World in Data, published as Number of clinical trials. Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

About this data

Indicator
Number of clinical trials
Unit
trials
Source
ClinicalTrials.gov (2025) – with major processing by Our World in Data
Licence
CC BY 4.0 (Our World in Data)
Coverage
153 places, 2,621 data points, 2000–2024
Last refreshed

Annual number of completed clinical trials registered in the ClinicalTrials.gov database for each country. Registration in the ClinicalTrials database is mandatory for trials in the United States, but voluntary for other countries.